Physicians who set their own fees determine the level of patient co-payment.
new prescription drugs
Drug developers are more likely to invest in research and development if prices for their medicines are high.
New clinical trials registered with Health Canada fell by more than 52 per cent.
Developing and testing new drugs costs a lot of money.
In a bid to get even steeper drug discounts, Health Canada recently proposed changes to our reference-pricing system.
Nobel laureate Paul Romer’s key new insight was that human capital can produce ideas.
Insurance companies are the principal beneficiaries of Ontario’s new publicly-funded pharmacare program.
Delay or denial of access to life-saving drugs is a potential death sentence.
Every province in Canada has a prescription drug insurance program for low-income and vulnerable citizens.